Victor Araujo Correa

Victor Araujo Correa

Auto-generated profile, based on publicly available information

Victor Araujo Correa

Adolfo Lutz Institute

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2022 in Immunology
Verified
Journal Article
Closed access
VCVictor Araujo Correa
Victor Araujo Correa
APAmanda Izeli Portilho
Amanda Izeli Portilho
Elizabeth De GaspariElizabeth De Gaspari
Elizabeth De Gaspari

21 December 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
FHFelipe Henriques
Felipe Henriques
MLMagno A. Lopes
Magno A. Lopes
FFFelipe O. Franco
Felipe O. Franco
PKPamela Knobl
Pamela Knobl
KSkaltinaitis santos
kaltinaitis santos
MJMiguel Luiz Batista Jr.
Miguel Luiz Batista Jr.
Cancer-induced cachexia, characterized by systemic inflammation, body weight loss, adipose tissue (AT) remodeling and muscle wasting, is a malignant metabolic syndrome with undefined etiology. Here, we show that both genetic ablation and pharmacological inhibition of TLR4 were able to attenuate the main clinical markers of cachexia in mice bearing Lewis lung carcinoma (LLC). AT remodelling was not found in LLC tumor-bearing (TB) TLR4−/−mice due to reduced macrophage infiltration and adipocyte atrophy. TLR4−/−mice were also resistant to cold-induced browning of subcutaneous AT (scAT). Importantly, pharmacological inhibition of TLR4 (Atorvastatin) reproduced the main protective effect against AT remodeling found in TLR4−/−TB mice. Moreover, the treatment was effective in prolonging survival and attenuating tumor mass growth when compared to non-treated-TB animals. Furthermore, tumor-induced elevation of circulating pro-inflammatory cytokines was similarly abolished in both genetic ablation and pharmacological inhibition of TLR4. These data suggest that TLR4 is a critical mediator and a promising target for novel anti-cachexia therapies.

1 July 2020 in Pathogens and Disease
Verified
Journal Article
Closed access
PDF file
GLGabriela Trzewikoswki de Lima
Gabriela Trzewikoswki de Lima
TRThais Sousa Rodrigues
Thais Sousa Rodrigues
APAmanda Izeli Portilho
Amanda Izeli Portilho
VCVictor Araujo Correa
Victor Araujo Correa
EGEmanuelle Baldo Gaspar
Emanuelle Baldo Gaspar
Elizabeth De GaspariElizabeth De Gaspari
Elizabeth De Gaspari
The elderly are more likely to die when infected with Neisseria meningitidis. Aging is associated with immune system dysfunctions that impair responses to vaccines and infections. Therefore, immunization of middle-aged individuals could be beneficial. This study aims to evaluate the immunogenicity of N. meningitidis B outer membrane vesicles (OMVs) complexed to two different adjuvants. Middle-aged BALB/c and A/Sn mice were immunized and subsequent immune response was assessed by ELISA, immunoblotting, and ELISpot. IgG levels were similar between the animals immunized with OMVs complexed to adjuvants. 235 days after the last immunization only A/Sn mice presented higher IgG levels than those observed in the baseline, especially the group immunized with OMVs and aluminum hydroxide. The predominant IgG subclasses were IgG2a and IgG2b. Immunization with the three-dose regimen generated IgG antibodies that recognized a variety of antigens present in the homologous and heterologous meningococcal OMVs evaluated. There was an increase in the frequency of antigen-specific IFN-γ secreting splenocytes, after in vitro stimulation, in mice immunized with OMVs and adjuvants compared to the control group, almost one year after the last immunization. Both adjuvants showed similar performance. Immunization of middle-aged mice has generated a robust immune response and it appears to be advantageous.

11 August 2022 in Immunological Investigations
Verified
Journal Article
Closed access
APAmanda Izeli Portilho
Amanda Izeli Portilho
VCVictor Araujo Correa
Victor Araujo Correa
CCCinthya dos Santos Cirqueira
Cinthya dos Santos Cirqueira
Elizabeth De GaspariElizabeth De Gaspari
Elizabeth De Gaspari
Immunization is the key to prevent invasive meningococcal disease (IMD), caused by Neisseria meningitidis. Outer membrane vesicles (OMVs) can be used as meningococcal antigens.Isogenic mice A/Sn (H...